BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Z, Nie S, Zhu H, Wu X, Jia S, Luo Y, Tang W. Association of p53 Arg72Pro polymorphism with bladder cancer: a meta-analysis. Gene 2013;512:408-13. [PMID: 23073555 DOI: 10.1016/j.gene.2012.09.085] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Othmane B, Yi Z, Zhang C, Chen J, Zu X, Fan B. Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology. Front Public Health 2022;10:1036722. [PMID: 36466542 DOI: 10.3389/fpubh.2022.1036722] [Reference Citation Analysis]
2 Pan H, Gu X, Wang X, Gao Z, Ding G, Zou C, Fan Y. Case–control study on TP73 rs1801173 C > T gene polymorphism and susceptibility to gastric cancer in a Chinese Han population. BMC Med Genomics 2022;15. [DOI: 10.1186/s12920-021-01151-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Garde-García H, Redondo-González E, Maestro-de Las Casas M, Fernández-Pérez C, Moreno-Sierra J. Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications. Clin Transl Oncol 2021;23:840-5. [PMID: 32839927 DOI: 10.1007/s12094-020-02476-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Shen CC, Cheng WY, Lee CH, Dai XJ, Chiao MT, Liang YJ, Hsieh WY, Mao TF, Lin GS, Chen SR, Liu BS, Chen JP. Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment. BMC Cancer 2020;20:709. [PMID: 32727419 DOI: 10.1186/s12885-020-07210-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Kawahara T, Kojima T, Kandori S, Kurobe M, Yoshino T, Kimura T, Nagumo Y, Ishituka R, Mitsuzuka K, Narita S, Kobayashi T, Matsui Y, Ogawa O, Sugimoto M, Miyazaki J, Nishiyama H. TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer. PLoS One. 2019;14:e0220173. [PMID: 31369573 DOI: 10.1371/journal.pone.0220173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang L, Wang Y, Qin Z, Li R, Cong R, Ji C, Meng X, Wang Y, Xia J, Song N. TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status. J Cancer 2018;9:3522-31. [PMID: 30310509 DOI: 10.7150/jca.26264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Mishchuk YM, Kharkivska YV, Serga SV, Shklyar SY, Stakhovskyi OE, Stakhovskyi EO, Vitruk YV, Kononenko AA, Demydov SV, Ostapchenko LI, Kozeretska IA. Association of TP53 Arg72Pro polymorphism (rs1042522) with bladder cancer risk in the Ukrainian population. Fakt eksp evol org 2018;23:214-218. [DOI: 10.7124/feeo.v23.1017] [Reference Citation Analysis]
8 Avirmed S, Wang BS, Selenge B, Sanjaajamts A, Ganbat B, Erdenebileg U, Purevsuren M, Jigjidsuren S, Batmunkh M, Lee YJ. Association between MDM2-SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population. Mol Clin Oncol 2017;7:412-20. [PMID: 28781817 DOI: 10.3892/mco.2017.1317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Bodoor K, Al-ghabkari A, Matalka I, Haddad Y, Alkhateeb A, Jaradat S, Jaradat ZW, Al-ghazo M, Abu-sheikha A, Jalboush SA, Jarun Y. Assessment of p53 mutations, expression and prognosis in bladder cancer patients from Jordan: Identification of novel deletion mutations in the DNA-binding domain. Meta Gene 2017;12:33-42. [DOI: 10.1016/j.mgene.2017.01.002] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Zhu J, Zhang B, Song W, Zhang X, Wang L, Yin B, Zhu F, Yu C, Li H. A literature review on the role of miR-370 in disease. Gene Reports 2016;4:37-44. [DOI: 10.1016/j.genrep.2016.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Zhou X, Zhang G, Tian Y, Seno M. p53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive Bladder Cancers Treated with Bacillus Calmette–Guérin: A Meta-Analysis. PLoS ONE 2015;10:e0119476. [DOI: 10.1371/journal.pone.0119476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
12 Panni S, Salvioli S, Santonico E, Langone F, Storino F, Altilia S, Franceschi C, Cesareni G, Castagnoli L. The adapter protein CD2AP binds to p53 protein in the cytoplasm and can discriminate its polymorphic variants P72R. J Biochem. 2015;157:101-111. [PMID: 25261582 DOI: 10.1093/jb/mvu059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
13 Pineda S, Milne RL, Calle ML, Rothman N, López de Maturana E, Herranz J, Kogevinas M, Chanock SJ, Tardón A, Márquez M, Guey LT, García-Closas M, Lloreta J, Baum E, González-Neira A, Carrato A, Navarro A, Silverman DT, Real FX, Malats N. Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis. PLoS One 2014;9:e89952. [PMID: 24818791 DOI: 10.1371/journal.pone.0089952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
14 Cai K, Wang Y, Zhao X, Bao X. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk. Tumour Biol 2014;35:1891-7. [PMID: 24114013 DOI: 10.1007/s13277-013-1254-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Wang L, Su G, Zhao X, Cai Y, Cai X, Zhang J, Liu J, Wang T, Wang J. Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk. Tumour Biol 2014;35:1139-42. [PMID: 24014088 DOI: 10.1007/s13277-013-1152-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
16 Liu C, Yin Q, Hu J, Weng J, Wang Y. Quantitative assessment of the association between XPG Asp1104His polymorphism and bladder cancer risk. Tumour Biol 2014;35:1203-9. [PMID: 24061640 DOI: 10.1007/s13277-013-1161-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]